From: Clinical utility of biomarkers of endothelial activation in sepsis-a systematic review
Study | Year | N | Population | Standard Criteria for SIRS/Sepsis | Associations with sepsis | Other outcomes |
---|---|---|---|---|---|---|
Shapiro et al., [51] | 2010 | 221 | ED patients with sepsis without organ dysfunction (71), severe sepsis without shock (66), septic shock (71), and non-infected controls (13) | 1992 ACCP/SCCM [1] | sICAM-1 elevated in septic shock compared with non-infected controls (P < 0.05); | sICAM-1 associated with increasing sepsis severity P < 0.05; modest correlation with SOFA and APACHE-II; predicts mortality and severe sepsis (AUC of 0.72 (95% CI 0.57 to 0.87), 0.61 (95% CI 0.53 to 0.69)) |
Schuetz et al., [52] | 2011 | 161 | Patients with hypotension: 69 sepsis 35 cardiac 12 hemorrhagic 12 unknown | Clinical classification based on clinical and microbiological data | ICAM-1 higher in sepsis compared to non-sepsis (P < 0.05) | Â |
Hofer et al., [55] | 2009 | 147 | Surgical ICU patients with severe sepsis (101) and major abdominal surgery (28), and healthy controls (18) | 2003 ACCP/SCCM [2] | sICAM-1 higher in the septic group than postoperative and volunteer groups at diagnosis (444.7 ng/ml vs 213.7 ng/ml and 219.6 ng/ml, respectively; P < 0.001) | Not predictive of mortality at the time of diagnosis of sepsis, but non-survivors had trend to higher sICAM-1 levels at 48 h and 120 h (683.2 vs 434.1 ng/ml, P = 0.067; 360.2 vs 467.8 ng/ml, P = 0.083, respectively) compared to survivors |
Stief et al., [54] | 2007 | 86 | ICU patients with Sepsis (62), healthy controls (24) | Clinical definition of sepsis | Higher in sepsis than controls (2.56 ug/ml vs 0.19 ug/ml; P < 0.05) | Â |
Scherpereel et al., [53] | 2006 | 90 | ICU patients with sepsis (63), SIRS (7), healthy controls (20) | 1992 ACCP/SCCM [1] | sICAM-1 higher in sepsis compared to SIRS P < 0.02 | sICAM-1 not predictive of mortality or severity of sepsis |
Kinoshita et al., [56] | 2002 | 56 | Gram negative sepsis from intra-abdominal infection admitted to surgical ICU (47), healthy controls (9) | 1992 ACCP/SCCM [1] | sICAM-1 higher in sepsis than healthy controls | Not correlated with mortality in those with ARDS; Higher in those with ARDS than those without P < 0.05 |
Paterson et al., [57] | 2000 | 16 | ICU patients with SIRS (10), healthy controls (6) | 1992 ACCP/SCCM [1] | sICAM-1 not reported in healthy controls | Not correlated with mortality |
Weigand et al., [58] | 1999 | 21 | Surgical ICU patients with septic shock (14), healthy controls (7) | 1992 ACCP/SCCM [1] | sICAM-1 significantly higher in sepsis than controls (P < 0.05) | sICAM-1 significantly higher in nonsurvivors than survivors, sensitivity and specificity for cutoff of 800 ng/ml was 74.1% |
Froon et al., [73] | 1998 | 42 | ICU patients with sepsis and VAP | 1992 ACCP/SCCM [1] | sICAM-1 higher in VAP patients complicated by severe sepsis or septic shock than other VAP patients, but statistical significance not achieved | Not predictive of mortality, and correlates poorly with SAPS-II (r = 0.16, P = 0.30) |
Kayal et al., [59] | 1998 | 41 | ICU patients with severe sepsis or septic shock (25), ICU controls (7), healthy controls (9) | 1992 ACCP/SCCM [1] | sICAM-1 higher in septic patients than in noninfected ICU controls and healthy volunteers (P < 0.0001); higher in septic shock than those without septic shock (P < 0.05) | sICAM-1 correlated with mortality; correlated with SAPS and MOF score (r = 0.53, P < 0.01 for MOF) |
Boldt et al., [60] | 1997 | 30 | Surgical ICU patients with post-operative sepsis (30), healthy controls (not stated) | 1992 ACCP/SCCM1 | sICAM-1 higher in septic patients than healthy controls | Higher in older than younger patients P < 0.05, and tends to increase in older patients and decrease in younger patients over time |
Egerer et al., [61] | 1997 | 24 | ICU patients with infection (8), severe sepsis (16) | 1992 ACCP/SCCM [1] | sICAM-1 higher in severe sepsis compared with patients with infection (P > 0.05) | Not correlated with mortality in patients with severe sepsis |
Takakuwa et al., [62] | 1997 | 34 | ICU admissions with sepsis (20), trauma (14) | Clinical definition of SIRS and sepsis | sICAM-1 level higher in septic than trauma patients (987.7 vs 472.1 ng/ml; P = 0.0002) | sICAM-1 correlated with endotoxin, TNF-α, IL-6, IL-8, Type II PLA2 (Type II phospholiaps A2), NO (P < 0.05 for all) |
Boldt et al., [63] | 1996 | 30 | Surgical ICU patients with postoperative sepsis (15), trauma (15) | 1992 ACCP/SCCM [1] | sICAM-1 higher in sepsis than trauma (1,266 vs 444 ng/ml; P < 0.01) | Â |
Endo et al., [64] | 1996 | 28 | ICU patients with sepsis with MOF (8), sepsis without MOF (15), MOF without sepsis (5) | Clinical diagnosis of sepsis | sICAM-1 higher in septic patients with or without MOF than patients with MOF but no infection (1103.3 vs 356.0 ng/ml, and 862.5 vs 356.0 ng/ml, respectively, P < 0.05)) | sICAM-1 level higher in septic patients with MOF than those without (P = 0.0401) |
Moss et al., [66] | 1996 | 55 | ICU patients with sepsis (19), trauma (36) controls (5) | Clinical diagnosis of sepsis | sICAM-1 higher in septic patients than trauma and controls (573 vs 148 and 235 ng/ml, respectively, P < 0.001) | Â |
Nakae et al., [67] | 1996 | 34 | ICU patients with sepsis (21), trauma (13) | 1992 ACCP/SCCM [1] | sICAM-1 higher in septic patients than in trauma patients (987 vs 472 pg/ml; P = 0.0002) | sICAM-1 correlated with endotoxin, TNF-alpha and IL-8 (P < 0.05 for all) |
Sessler et al., [68] | 1995 | 66 | ICU patients with sepsis (25), SIRS (25), ICU controls (4), healthy volunteers (12) | 1992 ACCP/SCCM [1] | sICAM-1 higher in sepsis than ICU controls and healthy controls (1,259 vs 585 ng/ml, P < 0.001; 1,259 vs 355 ng/ml, P < 0.0001); sICAM-1 is higher in SIRS than ICU controls and healthy controls (937 vs 585 ng/ml, P < 0.05; 937 vs 355 ng/ml, P < 0.001); higher in sepsis vs SIRS (1,259 vs 937 ng/ml; P = 0.12) | sICAM-1 elevated with increasing severity of illness: septic shock, severe sepsis and sepsis (1,551, 796, and 542 ng/ml, respectively, ANOVA P = 0.017); correlated with cumulative MOF score, shock severity score (r = 0.46, P = 0.021; r = 0.50, P < 0.009); higher in nonsurvivors vs survivors (1,697 vs 854 ng/ml; P = 0.0096) |
Cowley et al., [65] | 1994 | 125 | ICU patients with sepsis (21), severe sepsis (14), ICU controls (5), healthy controls (85) | Clinical definition of SIRS and sepsis | sICAM-1 higher in severe sepsis, uncomplicated sepsis, and ICU controls than healthy controls P < 0.05. | sICAM-1 with no significant difference between severe sepsis, uncomplicated sepsis and ICU controls. Not correlated with mortality |